Sign in
4

Changes in Ownership

INSMED Inc Filed Acc 0001628280-24-000698

Chief Commercial Officer sold 21,238 shares at an average $29.20 ($620,089)

  • Chief Commercial Officer acquired 20,071 shares (option exercise)
  • Chief Commercial Officer acquired 12,873 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Wise John Drayton · Chief Commercial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-03 Exercise or conversion : show line 1 in the form 10b5-1 +20,071 $19.11 $383,557 124,055 D
2024-01-03 Sale : show line 2 in the form 10b5-1 −20,071 $29.19 $585,872 103,984 D
2024-01-04 Grant or award : show line 3 in the form 10b5-1 +12,873 116,857 D
2024-01-05 Sale : show line 4 in the form 10b5-1 −1,167 $29.32 $34,216 115,690 D
Open-market sales · 21,238 sh · avg $29.20 · $620,089

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2024-01-03 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) −20,071 $19.11 2024-02-10 20,071 0 D
2024-01-04 Grant or award : show line 6 in the form 10b5-1 Stock Option (right to buy) +63,560 $29.13 2034-01-04 63,560 63,560 D
Loading xslF345X05/wk-form4_1704494003.xml…